EMORY UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1836-12-10

Employees: 10K

Market Cap: -

Website: http://www.emory.edu

Clinical Trials

Systems Biological Assessment of Statin Effect on Vaccine Responses

Phase 4

Active, not recruiting

Conditions: Vaccine Response

Interventions: Biological: Quadrivalent seasonal influenza vaccine
Drug: Atorvastatin

First Posted Date: 2023-09-05

Last Posted Date: 2024-10-02

Lead Sponsor: Emory University

Target Recruit Count: 86

Registration Number: NCT06024096

Locations: 🇺🇸
Hope Clinic, Atlanta, Georgia, United States

Embedded Primary Care MultiDisciplinary Diabetes Clinic

Not Applicable

Recruiting

Conditions: Diabetes Mellitus, Type 2

Interventions: Other: Routine Care
Other: Embedded Clinic

First Posted Date: 2023-08-29

Last Posted Date: 2023-12-07

Lead Sponsor: Emory University

Target Recruit Count: 180

Registration Number: NCT06015685

Locations: 🇺🇸
Emory Primary Clinic Care at Midtown, Atlanta, Georgia, United States

Proton Beam Radiation Therapy After Treatment for Resected N2 Non-Small Cell Lung Cancer

Phase 2

Not yet recruiting

Conditions: Resectable Lung Non-Small Cell Carcinoma

Interventions: Procedure: Biospecimen Collection
Radiation: Proton Beam Radiation Therapy
Other: Radiology, Treatment Planning

First Posted Date: 2023-08-24

Last Posted Date: 2024-06-06

Lead Sponsor: Emory University

Target Recruit Count: 20

Registration Number: NCT06008730

Locations: 🇺🇸
Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States

Cabozantinib in Combination With Atezolizumab for the Treatment of Patients With Locally Advanced, Metastatic, or Unresectable Adrenal Cortical Cancer

Phase 2

Active, not recruiting

Conditions: Adrenal Cortical Carcinoma
Stage III Adrenal Cortex Carcinoma
Stage IV Adrenal Cortex Carcinoma AJCC v8
Unresectable Adrenal Cortex Carcinoma
Locally Advanced Adrenal Cortex Carcinoma

Interventions: Biological: Atezolizumab
Procedure: Biospecimen Collection
Drug: Cabozantinib S-malate
Procedure: Computed Tomography
Procedure: Magnetic Resonance Imaging

First Posted Date: 2023-08-23

Last Posted Date: 2024-06-10

Lead Sponsor: Emory University

Target Recruit Count: 21

Registration Number: NCT06006013

Locations: 🇺🇸
Emory University Hospital Midtown, Atlanta, Georgia, United States
🇺🇸
Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States

Aldena STAR Particles

Not Applicable

Recruiting

Conditions: Healthy

Interventions: Device: STAR Particles

First Posted Date: 2023-08-22

Last Posted Date: 2024-08-06

Lead Sponsor: Emory University

Target Recruit Count: 20

Registration Number: NCT06004973

Locations: 🇺🇸
Emory Children's Center, Atlanta, Georgia, United States

Georgia Memory Net Anti-Amyloid Monoclonal Antibody Registry

Recruiting

Conditions: Alzheimer Disease

Interventions: Combination Product: Standard of Care
Drug: Anti-amyloid Monoclonal Antibodies (mAbs)

First Posted Date: 2023-08-21

Last Posted Date: 2024-10-03

Lead Sponsor: Emory University

Target Recruit Count: 735

Registration Number: NCT05999084

Locations: 🇺🇸
Georgia Memory Net Memory Assessment Clinic - Augusta, Augusta, Georgia, United States
🇺🇸
Georgia Memory Net Memory Assessment Clinic - Atlanta, Atlanta, Georgia, United States
🇺🇸
Georgia Memory Net Memory Assessment Clinic - Albany, Albany, Georgia, United States

and more 5 locations

Repurposing Atovaquone for the Treatment of Platinum-Resistant Ovarian Cancer

Phase 2

Recruiting

Conditions: Ovarian High Grade Serous Adenocarcinoma
Platinum-Resistant Ovarian Carcinoma

Interventions: Drug: Atovaquone
Procedure: Biopsy
Procedure: Computed Tomography
Procedure: Paracentesis

First Posted Date: 2023-08-18

Last Posted Date: 2024-08-07

Lead Sponsor: Emory University

Target Recruit Count: 28

Registration Number: NCT05998135

Locations: 🇺🇸
Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States

Walking Function in Diabetic Peripheral Neuropathy

Not Applicable

Recruiting

Conditions: Diabetic Peripheral Neuropathy

Interventions: Other: Clinical Evaluation
Other: Evaluation of Passive Ankle Stiffness
Other: Gait Biomechanics
Other: Gait Biofeedback
Other: Plantar Pressure Biofeedback Gait Training
Other: Propulsion Biofeedback Gait Training

First Posted Date: 2023-07-28

Last Posted Date: 2024-12-17

Lead Sponsor: Emory University

Target Recruit Count: 50

Registration Number: NCT05965336

Locations: 🇺🇸
Grady Memorial Hospital, Atlanta, Georgia, United States
🇺🇸
Emory Rehabilitation Hospital, Atlanta, Georgia, United States

Treatment of Long CoronaVirus Disease (COVID) (TLC) Feasibility Trial

Phase 3

Terminated

Conditions: COVID-19

Interventions: Drug: Cetirizine Placebo
Drug: Cetirizine
Drug: Famotidine Placebo
Drug: Famotidine

First Posted Date: 2023-07-14

Last Posted Date: 2024-08-21

Lead Sponsor: Emory University

Target Recruit Count: 5

Registration Number: NCT05946551

Locations: 🇺🇸
Grady Health System, Atlanta, Georgia, United States
🇺🇸
Emory Hospital, Atlanta, Georgia, United States
🇺🇸
Emory University Hospital Midtown, Atlanta, Georgia, United States

and more 1 locations

Comparison of Sepsis Prediction Algorithms

Not yet recruiting

Conditions: Sepsis

Interventions: Other: Epic Sepsis Model Version - 1
Other: Epic Sepsis Model Version - 2
Other: Emory Sepsis Model

First Posted Date: 2023-07-13

Last Posted Date: 2024-10-08

Lead Sponsor: Emory University

Target Recruit Count: 1200

Registration Number: NCT05943938

Locations: 🇺🇸
Emory Midtown Hospital, Atlanta, Georgia, United States
🇺🇸
Emory Saint Joseph's Hospital, Atlanta, Georgia, United States
🇺🇸
Emory Healthcare System, Atlanta, Georgia, United States

and more 4 locations

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy